Capital Impact Advisors, LLC Iradimed Corp Transaction History

Capital Impact Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$38.88 - $50.61 $68,856 - $89,630	-1,771 Reduced 9.13%	17,619 $841,000
Q1 2023 May 23, 2023	SELL	$28.48 - $42.14 $27,910 - $41,297	-980 Reduced 4.81%	19,390 $762,000
Q3 2022 Nov 21, 2022	BUY	$29.42 - $42.25 $35,715 - $51,291	1,214 Added 6.34%	20,370 $575,000
Q2 2022 Aug 15, 2022	SELL	$30.15 - $45.79 $109,776 - $166,721	-3,641 Reduced 15.97%	19,156 $650,000
Q1 2022 May 16, 2022	BUY	$36.01 - $53.14 $307,381 - $453,603	8,536 Added 59.86%	22,797 $1.02 Million
Q4 2021 Feb 14, 2022	BUY	$32.35 - $48.27 $461,343 - $688,378	14,261 New	14,261 $659,000

140

6.59M

Ticker IRMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 12,565,100
Market Cap $679M
Description
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible pati...

Get notified when there are updates to the investment portfolio of Capital Impact Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Capital Impact Advisors, LLC with notifications on news.